Pharmacotherapy represents the predominant first-line treatment in the management of most chronic and transient medical conditions warranting therapeutic intervention in Europe. This report covers oral, transdermal, inhalation, transmucosal, and injectable drug delivery devices. In 2007, European sales of these products totaled approximately $25 billion; over the forecast period covered by this report, sales are expected to increase at a compound annual growth rate of 11.2%, reaching more than $47 billion in the year 2013.
This new report by Medtech Insight presents a detailed overview of the European drug delivery products and technologies market. Major topics covered by this report include an overview of European healthcare markets; an overview of the biomechanics of drug delivery; discussions of drug delivery devices in the oral, transdermal, inhalation, transmucosal, and injectable market segments; and analyses of each of the sales and leading competitors in each of these markets.
(0 items)
